Company / R&D Expense
Neuronetics, Inc. R&D Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$9.5M
FY2025
5-year range
$7.9M / $13.7M
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 8 years, ranging from $8M in FY2023 to $14M in FY2021.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +2.9%.
Improved from $8M to $10M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.9%, indicating consistent growth.
- In FY2025, r&d expense increased 1.9% year-over-year.
- Peak r&d expense was recorded in FY2021.
- Lowest r&d expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.07 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.5M | +1.9% |
| FY2024 | $9.3M | +17.8% |
| FY2023 | $7.9M | -13.9% |
| FY2022 | $9.2M | -33.1% |
| FY2021 | $13.7M | +67.0% |
| FY2020 | $8.2M | +3.7% |
| FY2019 | $7.9M | -3.5% |
| FY2018 | $8.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026